| Bioactivity | AZP-531 is an analogue of unacylated ghrelin designed to improve glycaemic control and reduce weight. | ||||||
| Invitro | AZP-531 exerts survival effects on pancreatic b-cells and human pancreatic islets which is comparable to that of UAG, the parent molecule. AZP-531 is very stable in human plasma in vitro. No degradation is observed after 1 day of incubation at 37°C[1]. | ||||||
| Name | AZP-531 | ||||||
| CAS | 1088543-62-7 | ||||||
| Shortening | Cyclo(RVQSPEHQ) | ||||||
| Formula | C40H63N15O13 | ||||||
| Molar Mass | 962.02 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |